Omnicell, Inc.
OMCL
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $1.6B
$34.37
▼ -1.29%
P/E
40.20
Mkt Cap
$1.6B
52-Wk Range
$29.06–$55.00
52-Week Range
$29.06 - $55.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 6.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive integrated platform spanning point-of-care to central pharmacy automation
- Proprietary robotic and automation technology with significant switching costs
- Deep healthcare system relationships and established market presence since 1992
- Software ecosystem creating recurring revenue and customer lock-in through interface integration
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing hospital demand for medication automation to address nursing shortages and improve safety
Value
Attractively priced below Healthcare IT & Services peer average
Momentum
Weak
-18.1% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying OMCL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
JUL 30, 2026
Reported EPS of $0.94 vs $0.47 consensus (+101.1% surprise). Revenue of $312.2M vs $310.2M expected (+0.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+101.1%
Revenue trend · last 8Q
—
+19%
+10%
+5%
+10%
+2%
+15%
+7%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$282.4M
$306.9M
$269.7M
$290.6M
$310.6M
$314.0M
$309.9M
$312.2M
Margins · last 8Q
Gross
49.0%
Operating
10.4%
Profit
7.8%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: KeyBanc · Aug 24, 2026
vs Industry
How OMCL stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related